Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Misonix Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Misonix Inc (MSON) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q4 2021
Competitors
46
Named by the company
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
43.55 %
Q4 2021
Net Margin
-22.72 %
Q4 2021

Key Findings: Misonix Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 74M vs -M combined for its competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+6.4% annualized vs trailing 12 months).
  • Peer revenue share: Misonix Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

MSON Sales vs. its Competitors, Q4 2021

Misonix Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/MSON/competitors
https://api.csimarket.com/api/v1/companies/MSON/relationships
https://api.csimarket.com/api/v1/companies/MSON/similar
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API

For context: the Laboratory Analytical Instruments industry grew revenue 13.3% year over year, combined, vs 43.6% for Misonix Inc. Misonix Inc's share of combined industry revenue moved from 0.14% to 0.18%, a gain of 0.04 percentage points.

Misonix Inc's Competitor Quality Breadth

Group definitions: see Methodology: Performance Group Definitions.

Entity Profitable Expanding Above Industry Growth Distressed
Misonix Inc No Yes Yes No
High-Confidence Competitors (19) 53% 78% 61% 16%
Similar Growth & Profitability (8) 25.00 % (2 of 8) 100.00 % (8 of 8) 100.00 % (8 of 8) 25.00 % (2 of 8)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q4 2021

100%market share
  • Misonix Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Misonix Inc and its 46 competitors.

See Misonix Inc's full market share breakdown »

MSON Stock Performance relative to its Competitors

MSON Competitors (weighted) Percent change over the selected range

Misonix Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
47.1%beat U.S.A. 500
High-Confidence
(8 of 17)
66.7%beat U.S.A. 500
Similar Growth & Profitability
(2 of 3)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Misonix Inc - -
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (17) 40.4% 63.2%
Similar-Size Competitors (0) 40.4% 63.2%
Similar Growth & Profitability (3) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Misonix Inc's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

MSON Stock Performance relative to High-Confidence Competitors

MSON High-Confidence Competitors (equal-weighted, 20) Percent change over the selected range

MSON Stock Performance relative to Similar Growth & Profitability Competitors

MSON Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

Misonix Inc's Competitors Named by the Company

Competitive relationships identified from Misonix Inc reports and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Zimmer Biomet Holdings, Inc. Company report 85% 2022 to 2026 3
Anika Therapeutics Inc Company report 85% 2022 to 2026 3
Medtronic Company report 85% 2022 to 2026 3
Orthofix Medical Inc. Company report 85% 2022 to 2026 3
Enovis Company report 85% 2022 to 2026 3
NuVasive, Inc. Company report 85% 2022 to 2026 3
Globus Medical Inc. Company report 85% 2022 to 2026 3
Stryker Corporation Company report 85% 2022 to 2026 3
Sanofi S.A Company report 85% 2022 to 2026 3
Hanger Orthopedics Company report 85% 2022 to 2026 3
Organogenesis Holdings Inc Company report 85% 2022 to 2026 3
Curonix Company report 85% 2022 to 2026 3
Ferring Pharmaceutical Inc. Company report 85% 2022 to 2026 3
Johnson & Johnson Company report 85% 2022 to 2026 3
SPR Therapeutics Company report 85% 2022 to 2026 3
Arthrex, Inc. Company report 85% 2022 to 2026 3
Emcyte Corporation Company report 85% 2022 to 2026 3
Nalu Company report 85% 2022 to 2026 3
Söering Company report 85% 2022 to 2026 3
DePuy Orthopaedics, Inc. Company report 85% 2022 to 2026 3
Fidia Farmaceutici S.p.A. Company report 85% 2022 to 2026 3
Channel-Markers Medical Company report 85% 2022 to 2026 3
Integra Life Sciences, Inc. Company report 85% 2022 to 2026 3
XFT Medical Company report 85% 2022 to 2026 3
Xtant Medical Holdings Inc Company report 85% 2022 to 2026 3
Lifeward ltd Company report 85% 2022 to 2026 3
OrthogenRx Inc. (Avanos) Company report 85% 2022 to 2026 3
NAOV Company report 85% 2022 to 2026 3
Stimwave Company report 85% 2022 to 2026 3
Envue Medical Inc Company report 85% 2022 to 2026 3
Avanos Medical Inc Company report 85% 2022 to 2026 3
DePuy Orthopaedics, Inc. (Johnson & Johnson) Company report 85% 2022 to 2026 3
MiMedx Company report 85% 2022 to 2026 3
OrthogenRx Inc. Company report 85% 2022 to 2026 3
Asensus Surgical Inc Company report 85% 2022 to 2026 3
Medinotec Inc Company report 85% 2022 to 2026 3
Smith and Nephew Plc Company report 85% 2022 to 2026 3
Edwards Lifesciences Corporation Company report 85% 2022 to 2026 3
Utah Medical Products Inc Company report 85% 2022 to 2026 3
Conmed Corporation Company report 85% 2022 to 2026 3
Procept Biorobotics Corporation Company report 85% 2022 to 2026 3
Adagio Medical Holdings inc Company report 85% 2022 to 2026 3
Fuse Medical Inc Company report 85% 2022 to 2026 3
Zimvie Inc Company report 85% 2022 to 2026 3
Encision Inc Company report 85% 2022 to 2026 3
Teleflex Incorporated Company report 85% 2022 to 2026 3
Competitor Evidence Detail

Company report basis, confidence, active dates and source counts for Misonix Inc's named competitors require a Commercial License.

Methodology: see Methodology: Peer & Competitor Identification, Sourcing.

Get the full CSIMarket dataset: Subscribe API Connect Your AI